Which patent and where? Why international patent transparency by companies is needed for medicines

被引：0
|
作者：
Reed F Beall
Amir Attaran
机构：
[1] Reed F. Beall and Amir Attaran are in the Population Health Program,
[2] Faculties of Law and of Medicine,undefined
[3] University of Ottawa,undefined
[4] Ottawa,undefined
[5] Ontario,undefined
[6] Canada.,undefined
来源：
Nature Biotechnology | 2016年 / 34卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A common method for determining the patent status of medicines internationally is highly imprecise and complicates medicine access by obscuring the true medicine patent landscape for policymakers and procurement officers.
引用
收藏
页码：923 / 926
页数：3
相关论文
共 19 条
12